Inspiratory Muscle Training for Lung Transplant Candidates
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether special breathing exercises can help people awaiting a lung transplant recover better after surgery. The focus is on inspiratory muscle training (IMT), which strengthens the muscles used for breathing. Researchers aim to determine if this can improve recovery time and quality of life post-transplant. Suitable participants include those with lung diseases like Interstitial Lung Disease or COPD, who are already undergoing outpatient pulmonary rehab and are on the lung transplant waiting list. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance recovery for future lung transplant patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that inspiratory muscle training is safe for lung transplant candidates?
Research shows that inspiratory muscle training (IMT) is generally safe for many people, including those with long-term lung issues. Studies have found that IMT can improve exercise capacity and ease of breathing. Most people can engage in the training without major problems.
For individuals awaiting a lung transplant, IMT has strengthened their breathing muscles. One study found a significant improvement in muscle strength, suggesting the training's effectiveness. While some risks exist, as with any treatment, evidence indicates that IMT is safe for most participants.12345Why are researchers excited about this trial?
Researchers are excited about Inspiratory Muscle Training (IMT) for lung transplant candidates because it offers a targeted approach to strengthen the muscles used for breathing. Unlike standard rehabilitation programs that focus broadly on general fitness with aerobic, resistance, and flexibility training, IMT specifically enhances the strength and endurance of the respiratory muscles through twice-daily sessions. This targeted strengthening could potentially improve lung function and overall fitness in candidates awaiting transplants, making it a promising addition to traditional pre-transplant care.
What evidence suggests that inspiratory muscle training is effective for lung transplant candidates?
Research shows that Inspiratory Muscle Training (IMT) can aid individuals awaiting lung transplants by enhancing lung function and easing breathing. In this trial, participants in the IMT and exercise training group will perform twice-daily 30-breath IMT sessions. Studies have found that this regimen boosts exercise capacity and reduces fatigue in the breathing muscles. This training strengthens the muscles used for breathing, resulting in improved lung function and reduced shortness of breath. Although the direct benefits of IMT after a transplant remain unclear, these early findings suggest it may enhance overall breathing health before the transplant.13467
Who Is on the Research Team?
Dmitry Rozenberg, MD, PhD
Principal Investigator
University Health Network/University of Toronto
Are You a Good Fit for This Trial?
This trial is for adults over 18 awaiting lung transplants due to Interstitial Lung Disease or Chronic Obstructive Pulmonary Disease, who are already in outpatient pulmonary rehab. It's not for those with recent pneumothorax, severe heart issues, pacemakers, re-transplant candidates, internet access issues, recent respiratory flare-ups, ear problems that affect pressure regulation, severe osteoporosis with rib fractures history or certain neurological/musculoskeletal conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Transplant Inspiratory Muscle Training
Participants perform inspiratory muscle training (IMT) and exercise training sessions during the pre-lung transplant phase.
Post-Transplant Follow-up
Participants are monitored for safety and effectiveness after lung transplant, including assessments of respiratory muscle endurance and health-related quality of life.
Long-term Follow-up
Participants continue to be monitored for long-term outcomes and post-transplant recovery.
What Are the Treatments Tested in This Trial?
Interventions
- Inspiratory Muscle Training
Inspiratory Muscle Training is already approved in European Union, United States, Canada for the following indications:
- Chronic Obstructive Pulmonary Disease (COPD)
- Congestive Heart Failure
- Spinal Cord Injury
- Multiple Sclerosis
- Chronic Obstructive Pulmonary Disease (COPD)
- Congestive Heart Failure
- Spinal Cord Injury
- Multiple Sclerosis
- Cardiac Rehabilitation
- Chronic Obstructive Pulmonary Disease (COPD)
- Congestive Heart Failure
- Spinal Cord Injury
- Multiple Sclerosis
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor
Canadian National Transplant Research Program
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator
Ozmosis Research Inc.
Industry Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborator
Vancouver General Hospital
Collaborator